Recursion Pharmaceuticals: director Dar Zavain received 4,607 shares

What happened Dar Zavain, a director of Recursion Pharmaceuticals, received an award of 4,607 shares on Oct 1, 2026. The filing shows an acquisition price of $0.00 and a reported total value of $0.

Key details

• Transaction date and price: Oct 1, 2026; acquisition at $0.00 (code A: award/grant).
• Shares owned after the transaction: not reported in the filing.
• Footnote: F1 — the shares were issued pursuant to the issuer's outside director compensation policy.
• Filing timeliness: no late filing indicated.

Why it may matter

• This was an award/grant to a director, not a market purchase or sale of shares.
• A filing does not show why the insider traded or why the company acted.